SI2314609T1 - Derivat metastina in njegova uporaba - Google Patents
Derivat metastina in njegova uporabaInfo
- Publication number
- SI2314609T1 SI2314609T1 SI200931623A SI200931623A SI2314609T1 SI 2314609 T1 SI2314609 T1 SI 2314609T1 SI 200931623 A SI200931623 A SI 200931623A SI 200931623 A SI200931623 A SI 200931623A SI 2314609 T1 SI2314609 T1 SI 2314609T1
- Authority
- SI
- Slovenia
- Prior art keywords
- metastin derivative
- metastin
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008196598 | 2008-07-30 | ||
EP09803004.2A EP2314609B1 (en) | 2008-07-30 | 2009-07-29 | Metastin derivative and use thereof |
PCT/JP2009/063533 WO2010013762A1 (ja) | 2008-07-30 | 2009-07-29 | メタスチン誘導体およびその用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2314609T1 true SI2314609T1 (sl) | 2017-05-31 |
Family
ID=41610461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200931623A SI2314609T1 (sl) | 2008-07-30 | 2009-07-29 | Derivat metastina in njegova uporaba |
Country Status (13)
Country | Link |
---|---|
US (1) | US20110212890A1 (sl) |
EP (2) | EP2314609B1 (sl) |
JP (1) | JP5698977B2 (sl) |
CY (1) | CY1118975T1 (sl) |
DK (1) | DK2314609T3 (sl) |
ES (1) | ES2617657T3 (sl) |
HR (1) | HRP20170319T1 (sl) |
HU (1) | HUE030900T2 (sl) |
LT (1) | LT2314609T (sl) |
PL (1) | PL2314609T3 (sl) |
PT (1) | PT2314609T (sl) |
SI (1) | SI2314609T1 (sl) |
WO (1) | WO2010013762A1 (sl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5700641B2 (ja) * | 2008-04-30 | 2015-04-15 | 国立大学法人京都大学 | メタスチン誘導体およびその用途 |
JP5455661B2 (ja) | 2009-01-29 | 2014-03-26 | ギガフォトン株式会社 | 極端紫外光源装置 |
EP2755690B1 (en) * | 2011-08-04 | 2020-04-01 | Merck Sharp & Dohme B.V. | Kisspeptide-pentasaccharide conjugates |
JP6982621B2 (ja) | 2016-09-30 | 2021-12-17 | マイオバント サイエンシズ ゲーエムベーハー | 女性不妊の治療方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4343898A (en) | 1980-02-11 | 1982-08-10 | Novo Industri A/S | Process for preparing esters of human insulin |
US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
JP4486187B2 (ja) | 1998-10-27 | 2010-06-23 | 武田薬品工業株式会社 | 新規g蛋白質共役型レセプター蛋白質、そのdnaおよびそのリガンド |
US6638906B1 (en) * | 1999-12-13 | 2003-10-28 | Nobex Corporation | Amphiphilic polymers and polypeptide conjugates comprising same |
US6838259B2 (en) * | 1999-12-17 | 2005-01-04 | Takeda Chemical Industries, Ltd. | Process for producing kiss-1 peptide |
WO2001075104A1 (fr) | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Nouvelle proteine, adn codant pour celle-ci, et son procede de production |
WO2002085399A1 (en) | 2001-04-20 | 2002-10-31 | Takeda Chemical Industries, Ltd. | Peptide-containing preparations |
CA2460803A1 (en) * | 2001-09-19 | 2003-04-03 | Takeda Chemical Industries, Ltd. | Antibody against metastin and use thereof in diagnosing pregnancy |
AU2003201854A1 (en) * | 2002-01-11 | 2003-07-30 | Takeda Chemical Industries, Ltd. | PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
AU2003272964A1 (en) * | 2002-10-09 | 2004-05-04 | Kyowa Hakko Kogyo Co., Ltd. | Remedy for hormone-dependent cancer |
WO2004063221A1 (ja) * | 2002-12-26 | 2004-07-29 | Takeda Pharmaceutical Company Limited | メタスチン誘導体およびその用途 |
JP4804714B2 (ja) * | 2002-12-26 | 2011-11-02 | 武田薬品工業株式会社 | メタスチン誘導体およびその用途 |
US6800611B2 (en) * | 2003-01-06 | 2004-10-05 | Takeda Chemical Industries, Ltd. | Metastin derivatives and their use |
US7754220B2 (en) * | 2003-03-12 | 2010-07-13 | Takeda Pharmaceutical Company Limited | Methods of inhibiting secretion of follicle-stimulating hormone and testosterone |
WO2005117939A2 (en) * | 2004-04-23 | 2005-12-15 | Applied Research Systems Ars Holding N.V. | Use of gpcr54 ligands for the treatment of infertility |
PE20091567A1 (es) * | 2004-06-25 | 2009-11-03 | Takeda Pharmaceutical | Derivados de metastina en el tratamiento del cancer |
WO2007084211A2 (en) * | 2005-11-11 | 2007-07-26 | The General Hospital Corporation | Use of gpr54 ligands for treatment of reproductive disorders, proliferative disorders, and for contraception |
US20090093615A1 (en) * | 2005-12-22 | 2009-04-09 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
US8404643B2 (en) * | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
AR058584A1 (es) * | 2005-12-22 | 2008-02-13 | Takeda Pharmaceutical | Derivados de metastina y uso de los mismos |
US20090099334A1 (en) * | 2005-12-22 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
CA2647027A1 (en) * | 2006-03-20 | 2007-09-27 | Merck & Co., Inc. | Neuromedin u receptor agonists and uses thereof |
JP2009536611A (ja) * | 2006-03-28 | 2009-10-15 | バイオファルミカ リミテッド | ホルモン依存性障害の処置のための作用物質及びその使用 |
US8183212B2 (en) | 2006-04-26 | 2012-05-22 | Kyoto University | Compound having GPR54 agonistic activity |
JO3048B1 (ar) * | 2006-10-25 | 2016-09-05 | Takeda Pharmaceuticals Co | مشتقات متاستين واستخدامها |
JP4906476B2 (ja) | 2006-11-06 | 2012-03-28 | 株式会社ブリヂストン | タイヤ加硫モールドの洗浄方法 |
JP2009058102A (ja) | 2007-09-03 | 2009-03-19 | Akebono Brake Ind Co Ltd | パッドクリップ及び多板ディスクブレーキ |
CA2701612A1 (en) * | 2007-10-05 | 2009-04-09 | Takeda Pharmaceutical Company Limited | Neuromedin u derivative |
-
2009
- 2009-07-29 EP EP09803004.2A patent/EP2314609B1/en active Active
- 2009-07-29 PL PL09803004T patent/PL2314609T3/pl unknown
- 2009-07-29 US US13/056,297 patent/US20110212890A1/en not_active Abandoned
- 2009-07-29 ES ES09803004.2T patent/ES2617657T3/es active Active
- 2009-07-29 HU HUE09803004A patent/HUE030900T2/en unknown
- 2009-07-29 WO PCT/JP2009/063533 patent/WO2010013762A1/ja active Application Filing
- 2009-07-29 PT PT98030042T patent/PT2314609T/pt unknown
- 2009-07-29 DK DK09803004.2T patent/DK2314609T3/en active
- 2009-07-29 SI SI200931623A patent/SI2314609T1/sl unknown
- 2009-07-29 LT LTEP09803004.2T patent/LT2314609T/lt unknown
- 2009-07-29 EP EP16196765.8A patent/EP3210998A1/en not_active Withdrawn
- 2009-07-29 JP JP2010522744A patent/JP5698977B2/ja active Active
-
2017
- 2017-02-27 HR HRP20170319TT patent/HRP20170319T1/hr unknown
- 2017-02-28 CY CY20171100265T patent/CY1118975T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1118975T1 (el) | 2018-01-10 |
ES2617657T3 (es) | 2017-06-19 |
EP2314609A1 (en) | 2011-04-27 |
PL2314609T3 (pl) | 2017-07-31 |
DK2314609T3 (en) | 2017-03-13 |
US20110212890A1 (en) | 2011-09-01 |
HUE030900T2 (en) | 2017-06-28 |
JPWO2010013762A1 (ja) | 2012-01-12 |
PT2314609T (pt) | 2017-03-06 |
WO2010013762A1 (ja) | 2010-02-04 |
EP2314609B1 (en) | 2016-11-30 |
LT2314609T (lt) | 2017-04-10 |
EP2314609A4 (en) | 2013-01-16 |
HRP20170319T1 (hr) | 2017-05-05 |
JP5698977B2 (ja) | 2015-04-08 |
EP3210998A1 (en) | 2017-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180718T1 (hr) | Oligopeptidni spojevi i njihova upotreba | |
HK1196358A1 (en) | Substituted pyridin-2-ones and pyridazin-3-ones -2--3- | |
IL211042A0 (en) | Imidazopyridin-2-one derivatives and uses thereof | |
ZA201103635B (en) | Azaquinolinone derivatives and uses thereof | |
EP2264017A4 (en) | Heterocyclic derivative and its use | |
IL210804A (en) | Benzylidenehydrazides and their uses | |
GB0818241D0 (en) | Compounds and their use | |
EP2277900A4 (en) | METASTIN DERIVATIVE AND USE THEREOF | |
IL208081A0 (en) | Amido - thiophene compounds and their use | |
IL198046A0 (en) | Metastin derivatives and use thereof | |
ZA201007395B (en) | Aryl-quinolyl compounds and their use | |
SI2344449T1 (sl) | Aril-fenil-sulfonamido-cikloalkilne spojine in njihova uporaba | |
IL208771A0 (en) | Iminopyridine derivatives and use thereof | |
ZA201103456B (en) | Leukolectins and uses thereof | |
EP2291377A4 (en) | IMIDAZOPYRIMIDINONE AND ITS USES | |
EP2275433A4 (en) | METASTIN DERIVATIVE AND USE THEREOF | |
EP2247601A4 (en) | THIAZOPYRIMIDINONE AND APPLICATIONS THEREOF | |
EP2213675A4 (en) | PYRIDOOXAZEPINE DERIVATIVE AND USE THEREOF | |
SI2314609T1 (sl) | Derivat metastina in njegova uporaba | |
IL208824A0 (en) | Iminopyridine derivative and use thereof | |
GB0801319D0 (en) | Compounds and their use | |
ZA200902452B (en) | Metastin derivatives and use thereof | |
IL206951A0 (en) | 3-alkyl-piperazine derivatives and uses thereof | |
EP2274294A4 (en) | 5-DIMETHOXY FUMAGILLOL AND ITS DERIVATIVES | |
GB0813359D0 (en) | Halfin and/or platerfin |